de Dios, C., Vij, R., Kim, H., Park, H., & Chang, D. (2023). Safety of multiple intravenous infusions of adipose-derived mesenchymal stem cells for hospitalized cases of COVID-19: A randomized controlled trial. Frontiers in medicine, 10, 1321303. https://doi.org/10.3389/fmed.2023.1321303
Chicago Style (17th ed.) Citationde Dios, Constanza, Ridhima Vij, Hosu Kim, Hyeonggeun Park, and Donna Chang. "Safety of Multiple Intravenous Infusions of Adipose-derived Mesenchymal Stem Cells for Hospitalized Cases of COVID-19: A Randomized Controlled Trial." Frontiers in Medicine 10 (2023): 1321303. https://doi.org/10.3389/fmed.2023.1321303.
MLA (9th ed.) Citationde Dios, Constanza, et al. "Safety of Multiple Intravenous Infusions of Adipose-derived Mesenchymal Stem Cells for Hospitalized Cases of COVID-19: A Randomized Controlled Trial." Frontiers in Medicine, vol. 10, 2023, p. 1321303, https://doi.org/10.3389/fmed.2023.1321303.